DIABETIC BLINDNESS

This adverse event was reported 99 times

These drugs are most commonly taken by patients reporting DIABETIC BLINDNESS:

# Drug Count
0 INSULIN LISPRO 23
1 INSULIN GLARGINE 19
2 INSULIN ASPART 10
3 INSULIN HUMAN 10
4 ADALIMUMAB 5
5 ATENOLOL 5
6 HUMAN INSULIN 5
7 QUETIAPINE 5
8 ESOMEPRAZOLE MAGNESIUM 4
9 DULAGLUTIDE 3
See all common drugs associated with DIABETIC BLINDNESS

DIABETIC BLINDNESS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 HUMAN INSULIN 5 0.0007
1 EMPAGLIFLOZIN AND LINAGLIPTIN 1 0.0005
2 CEFADROXIL 1 0.0005
3 INSULIN ASPART INJECTION 1 0.0004
4 INSULIN HUMAN 10 0.0003
5 CLINDAMYCIN PHOSPHATE 1 0.0002
6 INSULIN LISPRO 23 0.0002
7 INSULIN ASPART 10 0.0002
8 PARICALCITOL 2 0.0001
9 LIDOCAINE PATCH 5% 1 0.0001
See all drugs enriched for association with DIABETIC BLINDNESS

DIABETIC BLINDNESS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Insulin [EPC] 14 0.0003
1 Vitamin D2 Analog [EPC] 2 0.0003
2 Vitamin D Analog [EPC] 2 0.0001
3 Insulin Analog [EPC] 44 0.0001
4 Anti-anginal [EPC] 1 0.0001
5 Stimulant Laxative [EPC] 1 0.0001
6 Provitamin D2 Compound [EPC] 2 0.0001
7 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 5 0.0000
8 Aluminum Complex [EPC] 1 0.0000
9 Androgen [EPC] 1 0.0000
See all drug classes enriched for association with DIABETIC BLINDNESS